The volume of shares traded has dropped off today. Hopefully the sell-off after the rights issue is now finished. It was a very positive annual report. I have faith that API will grow strongly due to thier strong position in the pharmacueticals market and the action they are taking to reduce distribution costs.
The above comments not to be contrued as financial advice.